Home/Filings/4/0001140361-12-049838
4//SEC Filing

SPENCE A MICHAEL 4

Accession 0001140361-12-049838

CIK 0001398659other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:18 PM ET

Size

14.8 KB

Accession

0001140361-12-049838

Insider Transaction Report

Form 4
Period: 2012-12-03
Transactions
  • Exercise/Conversion

    Employee Stock Options (Right to Buy)

    2012-12-0345,00047,353 total
    Exercise: $3.04Exp: 2015-09-28Common Shares (45,000 underlying)
  • Exercise/Conversion

    Common Shares

    2012-12-03$3.04/sh+45,000$136,60765,421 total
  • Sale

    Common Shares

    2012-12-03$15.91/sh45,000$715,95020,421 total
  • Exercise/Conversion

    Common Shares

    2012-12-04$3.04/sh+47,353$143,75067,774 total
  • Sale

    Common Shares

    2012-12-04$15.69/sh47,353$742,97320,421 total
  • Exercise/Conversion

    Employee Stock Options (Right to Buy)

    2012-12-0447,3530 total
    Exercise: $3.04Exp: 2015-09-28Common Shares (47,353 underlying)
Footnotes (5)
  • [F1]The exercise price reflects an adjustment that was made to preserve the value of the Reporting Person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.
  • [F2]Includes restricted stock units (RSUs) granted under the Genpact Limited 2007 Omnibus Incentive Compensation Plan and reflects an adjustment that was made to preserve the value of the Reporting Person's outstanding RSUs following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.
  • [F3]The option vested over a five-year period commencing April 1, 2005.
  • [F4]The number of derivative securities beneficially owned reflects an adjustment that was made to preserve the value of the Reporting Person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.
  • [F5]The price in column 4 is a weighted average price. The actual sale prices for these transactions ranged from $15.6900 to $15.7000. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Documents

1 file

Issuer

Genpact LTD

CIK 0001398659

Entity typeother

Related Parties

1
  • filerCIK 0001201679

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:18 PM ET
Size
14.8 KB